Ratings Chemplast Sanmar Limited Bombay S.E.

Equities

CHEMPLASTS

INE488A01050

Market Closed - Bombay S.E. Other stock markets 06:00:49 2024-04-26 am EDT			5-day change	1st Jan Change
496.6 ^INR	-0.89%		+3.66%	-0.59%

Feb. 28	Chemplast Sanmar Begins Commercial Production from New Unit in Cuddalore, India	MT
Feb. 13	Transcript : Chemplast Sanmar Limited, Q3 2024 Earnings Call, Feb 13, 2024

Summary

On the basis of various fundamental qualitative criteria, the company appears to be particularly poorly ranked from a medium and long-term investment perspective.
From a short-term investment perspective, the company presents a deteriorated fundamental configuration.

Strengths

The earnings growth currently anticipated by analysts for the coming years is particularly strong.
Analysts have a positive opinion on this stock. Average consensus recommends overweighting or purchasing the stock.
The divergence of price targets given by the various analysts who make up the consensus is relatively low, suggesting a consensus method of evaluating the company and its prospects.

Weaknesses

According to Standard & Poor's' forecast, revenue growth prospects are expected to be very low for the next fiscal years.
In relation to the value of its tangible assets, the company's valuation appears relatively high.
The firm pays small or no dividend to shareholders. For that reason, it is not a yield company.
For the last twelve months, the trend in sales revisions has been clearly going down, which emphasizes downgraded expectations from the analysts.
The company's sales previsions for the coming years have been revised downwards, which foreshadows another slowdown in business.
For the past year, analysts have significantly revised downwards their profit estimates.
For the last four months, earnings estimated by analysts have been revised downwards with respect to the next two years.
The overall consensus opinion of analysts has deteriorated sharply over the past four months.
Over the past twelve months, analysts' opinions have been revised negatively.
Sales estimates for the next fiscal years vary from one analyst to another. This clearly highlights a lack of visibility into the company's future activity.
The group usually releases earnings worse than estimated.

Ratings chart - Surperformance

Chart ESG Refinitiv

Sector: Specialty Chemicals

	1st Jan change	Capi.	ESG Refinitiv
CHEMPLAST SANMAR LIMITED	-0.59%	941M	C-
ECOLAB INC.	+11.47%	63.22B	A-
SIKA AG	-3.47%	46.34B	A-
GIVAUDAN SA	+13.72%	39.97B	B+
FUJIFILM HOLDINGS CORPORATION	+17.83%	25.46B	A-
EMS-CHEMIE HOLDING AG	+7.27%	18.68B	C+
CELANESE CORPORATION	-0.57%	17.24B	B+
POSCO FUTURE M CO., LTD.	-21.73%	15.81B	A-
SYMRISE AG	+0.22%	14.9B	B+
ALBEMARLE CORPORATION	-19.10%	13.74B	C+

Investor Rating

Trading Rating

ESG Refinitiv

Financials

Sales growth

Earnings Growth

EBITDA / Sales

Profitability

Finances

Valuation

P/E ratio

EV / Sales

Price to Book

Price to Free Cash Flow

Yield

Momentum

1 year Revenue revision

4 months Revenue revision

7 days Revenue revision

1 year EPS revision

4 months EPS revision

Consensus

Analyst Opinion

Potential Price Target

4m Target Price Revision

4m Revision of opinion

12m Revision of opinion

Business Predictability

Analyst Coverage

Divergence of Estimates

Divergence of analysts' opinions

Divergence of Target Price

Earnings quality

Environment

Emissions

Innovation

Use of resources

Governance

CSR Strategy

Management

Shareholders

Controversy

Technical analysis

ST Timing

MT Timing

LT Timing

RSI

Bollinger Spread

Unusual volumes